Study on Rosuvastatin+Ezetimibe and Rosuvastatin for LDL-C Goal in Patients With Recent Ischemic Stroke
Status:
Recruiting
Trial end date:
2020-11-12
Target enrollment:
Participant gender:
Summary
A randomized clinical trial for the comparison of the efficacy and safety of
moderate-intensity rosuvastatin plus ezetimibe versus high-intensity rosuvastatin for target
LDL-C goal achievement in patients with recent ischemic stroke
Phase:
Phase 4
Details
Lead Sponsor:
Keun-Sik Hong
Collaborators:
Chung-Ang University Hosptial, Chung-Ang University College of Medicine Ewha Womans University Ewha Womans University Seoul Hospital Hallym University Medical Center Inje University Korea University Korea University Guro Hospital Kyunghee University Medical Center Myongji Hospital Samsung Medical Center Seoul National University Hospital Seoul St. Mary's Hospital Severance Hospital